PHARMACEUTICAL PRODUCT DEVELOPMENT INC Common Stock Dividends Paid
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Common Stock Dividends Paid of $52.82 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsCommonStock · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for the quarter ending 2011-09-30 was $17.13M, a 4.00% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for the quarter ending 2011-06-30 was $16.71M, a 6.15% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for the quarter ending 2011-03-31 was $18.98M, a 6.78% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for the quarter ending 2010-12-31 was $17.87M, a 0.70% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for fiscal 2010 was $71.30M, a 4.95% increase from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for fiscal 2009 was $67.93M, a 34.67% increase from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments of ordinary dividends, common stock for fiscal 2008 was $50.44M.
| Period end | Payments of Ordinary Dividends, Common Stock 3 month | Payments of Ordinary Dividends, Common Stock 6 month | Payments of Ordinary Dividends, Common Stock 9 month | Payments of Ordinary Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2011-09-30 | $17.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $33.84M derived: sum of 2 quarters · filed 2011-11-02 | $52.82M 10-Q · filed 2011-11-02 | $70.69M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $16.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $35.69M 10-Q · filed 2011-08-04 | $53.56M derived: sum of 3 quarters · filed 2011-08-04 | $71.41M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $18.98M 10-Q · filed 2011-05-03 | $36.86M derived: sum of 2 quarters · filed 2011-05-03 | $54.70M derived: sum of 3 quarters · filed 2011-11-02 | $72.50M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $17.87M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $35.71M derived: sum of 2 quarters · filed 2011-11-02 | $53.52M derived: sum of 3 quarters · filed 2011-11-02 | $71.30M 10-K · filed 2011-02-25 |
| 2010-09-30 | $17.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $35.65M derived: sum of 2 quarters · filed 2011-11-02 | $53.42M 10-Q · filed 2011-11-02 | $71.17M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $17.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $35.58M 10-Q · filed 2011-08-04 | $53.33M derived: sum of 3 quarters · filed 2011-08-04 | $71.08M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $17.78M 10-Q · filed 2011-05-03 | $35.53M derived: sum of 2 quarters · filed 2011-05-03 | $53.27M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | $17.75M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $35.50M derived: sum of 2 quarters · filed 2011-02-25 | $67.93M 10-K · filed 2011-02-25 | |
| 2009-09-30 | $17.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $50.18M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $32.43M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $50.44M 10-K · filed 2011-02-25 |